Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| BARD C R INC /NJ/BCR · Entity 170698 | Director | December 29, 2017 | January 03, 2018 |
| Carlyle Group Inc.CG · Entity 3316 | Director | May 01, 2026 | May 01, 2026 |
| GILEAD SCIENCES, INC.GILD · Entity 405 | Director | August 26, 2026 | August 27, 2026 |
| LOEWS CORPL · Entity 3231 | Director | March 03, 2025 | March 04, 2025 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
BARD C R INC /NJ/
Report date December 29, 2017 · Filed January 03, 2018
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 0 |
Reported balance
After 2017-12-29 transaction · row 1
1 source rowRow 1 · 2017-12-29 · Disposition to issuer · Disposed 4,520 · Balance 0 F1: This Form 4 is being filed in connection with the December 29, 2017 closing of the merger (the "Merger") of Lambda Corp. ("Lambda") with and into C. R. Bard, Inc. ("Bard") pursuant to the Agreement and Plan of Merger, dated as of April 23, 2017, among Bard, Becton, Dickinson and Company ("BD") and Lambda. Upon the closing of the Merger, each outstanding share of Bard common stock was converted into the right to receive $222.93 in cash (without interest) and 0.5077 of a share of BD common stock (the "Merger Consideration"). |
| Phantom Stock UnitsSEC Table II · derivative / convertible security | Direct | 20,596.9 |
Reported balance
After 2017-12-29 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2017-12-29 · Grant · Acquired 83.42 · Balance 20,596.9 F2: Units are credited under the Company's Deferred Compensation Contract, Deferral of Directors' Fees. F3: Conversion is 1 for 1. F4: Phantom stock units are settled in cash upon termination of service as director. F5: Includes 32.86 units for dividend credits. |
| Phantom Stock UnitsSEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2017-12-29 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2017-12-29 · Disposition to issuer · Disposed 20,596.9 · Balance 0 F2: Units are credited under the Company's Deferred Compensation Contract, Deferral of Directors' Fees. F3: Conversion is 1 for 1. F6: These units, which are 100% vested, were paid out in cash in accordance with the Merger Agreement. |
| Share Equivalent UnitsSEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2017-12-29 transaction · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · 2017-12-29 · Disposition to issuer · Disposed 17,808 · Balance 0 F7: Units granted under the Company's Stock Equivalent Plan for Outside Directors. F3: Conversion is 1 for 1. F8: These units, which are 100% vested, were assumed by BD at the effective time of the Merger. |
Filing footnotes · ownership attribution and instrument terms
F1: This Form 4 is being filed in connection with the December 29, 2017 closing of the merger (the "Merger") of Lambda Corp. ("Lambda") with and into C. R. Bard, Inc. ("Bard") pursuant to the Agreement and Plan of Merger, dated as of April 23, 2017, among Bard, Becton, Dickinson and Company ("BD") and Lambda. Upon the closing of the Merger, each outstanding share of Bard common stock was converted into the right to receive $222.93 in cash (without interest) and 0.5077 of a share of BD common stock (the "Merger Consideration").
F2: Units are credited under the Company's Deferred Compensation Contract, Deferral of Directors' Fees.
F3: Conversion is 1 for 1.
F4: Phantom stock units are settled in cash upon termination of service as director.
F5: Includes 32.86 units for dividend credits.
F6: These units, which are 100% vested, were paid out in cash in accordance with the Merger Agreement.
F7: Units granted under the Company's Stock Equivalent Plan for Outside Directors.
F8: These units, which are 100% vested, were assumed by BD at the effective time of the Merger.
Carlyle Group Inc.
Report date May 01, 2026 · Filed May 01, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 47,849 |
Reported balance
After 2026-05-01 transaction · row 1
1 source rowRow 1 · 2026-05-01 · Grant · Acquired 4,450 · Balance 47,849 F1: These securities are a restricted stock unit award granted under The Carlyle Group Inc. Amended & Restated 2012 Equity Incentive Plan. These securities will vest on May 1, 2027, subject to the reporting person's continued service on the Issuer's Board of Directors on such vesting date. |
Filing footnotes · ownership attribution and instrument terms
F1: These securities are a restricted stock unit award granted under The Carlyle Group Inc. Amended & Restated 2012 Equity Incentive Plan. These securities will vest on May 1, 2027, subject to the reporting person's continued service on the Issuer's Board of Directors on such vesting date.
GILEAD SCIENCES, INC.
Report date August 26, 2026 · Filed August 27, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 12,894 |
Ending reported balance
After 2026-08-26 transaction · row 6
6 source rows · reconciled sequenceRow 1 · 2026-08-26 · Exercise / conversion · Acquired 7,718 · Balance 20,612 F1: The transactions reported in this Form 4 are made pursuant to a Rule 10b5-1 trading plan adopted on May 27, 2026. Row 2 · 2026-08-26 · Sale · Disposed 3,118 · Balance 17,494 F1: The transactions reported in this Form 4 are made pursuant to a Rule 10b5-1 trading plan adopted on May 27, 2026. F2: Sale prices for the transactions reported range from $147.58 to $148.5799. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer, or its shareowners upon request. Row 3 · 2026-08-26 · Sale · Disposed 4,600 · Balance 12,894 F1: The transactions reported in this Form 4 are made pursuant to a Rule 10b5-1 trading plan adopted on May 27, 2026. F3: Sale prices for the transactions reported range from $148.58 to $149.5799. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer, or its shareowners upon request. Row 4 · 2026-08-26 · Exercise / conversion · Acquired 10,282 · Balance 23,176 F1: The transactions reported in this Form 4 are made pursuant to a Rule 10b5-1 trading plan adopted on May 27, 2026. Row 5 · 2026-08-26 · Sale · Disposed 3,402 · Balance 19,774 F1: The transactions reported in this Form 4 are made pursuant to a Rule 10b5-1 trading plan adopted on May 27, 2026. F4: Sale prices for the transactions reported range from $147.57 to $148.5699. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer, or its shareowners upon request. Row 6 · 2026-08-26 · Sale · Disposed 6,880 · Balance 12,894 F1: The transactions reported in this Form 4 are made pursuant to a Rule 10b5-1 trading plan adopted on May 27, 2026. F5: Sale prices for the transactions reported range from $148.57 to $149.5699. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer, or its shareowners upon request. |
| Non-qualified Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $60.67 · Expires 2030-10-22 | Direct | 0 |
Reported balance
After 2026-08-26 transaction · row 7
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 7 · 2026-08-26 · Exercise / conversion · Disposed 7,718 · Balance 0 F1: The transactions reported in this Form 4 are made pursuant to a Rule 10b5-1 trading plan adopted on May 27, 2026. F6: 100% of the shares subject to the stock option vested immediately upon the grant date of October 22, 2020. |
| Non-qualified Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $61.35 · Expires 2032-05-05 | Direct | 5,569 |
Reported balance
After 2026-08-26 transaction · row 8
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 8 · 2026-08-26 · Exercise / conversion · Disposed 10,282 · Balance 5,569 F1: The transactions reported in this Form 4 are made pursuant to a Rule 10b5-1 trading plan adopted on May 27, 2026. F7: 25% of the shares subject to the option vested on each three-month anniversary measured from October 22, 2020 such that 100% of the shares subject to the option were fully vested and exercisable on October 22, 2021. |
Filing footnotes · ownership attribution and instrument terms
F1: The transactions reported in this Form 4 are made pursuant to a Rule 10b5-1 trading plan adopted on May 27, 2026.
F2: Sale prices for the transactions reported range from $147.58 to $148.5799. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer, or its shareowners upon request.
F3: Sale prices for the transactions reported range from $148.58 to $149.5799. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer, or its shareowners upon request.
F4: Sale prices for the transactions reported range from $147.57 to $148.5699. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer, or its shareowners upon request.
F5: Sale prices for the transactions reported range from $148.57 to $149.5699. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer, or its shareowners upon request.
F6: 100% of the shares subject to the stock option vested immediately upon the grant date of October 22, 2020.
F7: 25% of the shares subject to the option vested on each three-month anniversary measured from October 22, 2020 such that 100% of the shares subject to the option were fully vested and exercisable on October 22, 2021.
LOEWS CORP
Report date March 03, 2025 · Filed March 04, 2025
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 9,845 |
Ending reported balance
After 2025-03-03 transaction · row 3
3 source rows · reconciled sequenceRow 1 · 2025-03-03 · Exercise / conversion · Acquired 2,250 · Balance 12,095 F1: The transactions reported in this Form 4 were pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 26, 2024. Row 2 · 2025-03-03 · Disposition to issuer · Disposed 1,053 · Balance 11,042 F1: The transactions reported in this Form 4 were pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 26, 2024. Row 3 · 2025-03-03 · Sale · Disposed 1,197 · Balance 9,845 F1: The transactions reported in this Form 4 were pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 26, 2024. |
| Stock Appreciation RightSEC Table II · derivative / convertible security · Conversion / exercise price $40.61 · Expires 2025-03-31 | Direct | 0 |
Reported balance
After 2025-03-03 transaction · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · 2025-03-03 · Exercise / conversion · Disposed 2,250 · Balance 0 F1: The transactions reported in this Form 4 were pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 26, 2024. F2: The Reporting Person received the Derivative Security pursuant to a stock appreciation right grant at no cost. |
Filing footnotes · ownership attribution and instrument terms
F1: The transactions reported in this Form 4 were pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 26, 2024.
F2: The Reporting Person received the Derivative Security pursuant to a stock appreciation right grant at no cost.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
UNITEDHEALTH GROUP INC
Report date June 05, 2012 · Filed June 07, 2012
Section 16 reporting ended · disclosed 2012-06-07. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 119,908.836 |
Reported balance
After 2012-06-05 transaction · row 1
1 source rowRow 1 · 2012-06-05 · Tax withholding · Disposed 7,211 · Balance 119,908.836 |
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| September 12, 2017 Filed Sep 14, 2017 18:03 UTC | LOEWS CORP L · Entity 3231 | GrantRestricted Stock Units · Derivative | 2.8 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-17-035475 · doc1.xml · derivative · entry 1 WELTERS ANTHONY · CIK 0001213307 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,136.6 Underlying: Common Stock · 2.8 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's common stock. F2 · shares: Represents additional RSUs awarded to the Reporting Person on account of dividend equivalent rights associated with RSUs awarded on May 9, 2017 (the "2017 RSUs"). F3 · derivative.exercise_date: These RSUs vest, and shares of the Issuer's common stock will be delivered to the Reporting Person, concurrently with the 2017 RSUs, which will vest on May 9, 2018, subject to any election to defer delivery of shares made by the Reporting Person with respect to such 2017 RSUs. F3 · derivative.expiration_date: These RSUs vest, and shares of the Issuer's common stock will be delivered to the Reporting Person, concurrently with the 2017 RSUs, which will vest on May 9, 2018, subject to any election to defer delivery of shares made by the Reporting Person with respect to such 2017 RSUs. Read SEC document |
| July 03, 2017 Filed Jul 5, 2017 16:21 UTC | BARD C R INC /NJ/ BCR · Entity 170698 | GrantPhantom Stock Units · Derivative | 169.1 | $316.39 | $53,501.55 |
DisclosureSEC source: 0001225208-17-012202 · doc4.xml · derivative · entry 1 WELTERS ANTHONY · CIK 0001213307 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,480.62 Underlying: Common Stock · 169.1 shares Expires not disclosed F1 · security: Units are credited under the Company's Deferred Compensation Contract, Deferral of Directors' Fees. F2 · derivative.exercise_price: Conversion is 1 for 1. F3 · derivative.exercise_date: Phantom stock units are settled in cash upon termination of service as director. F3 · derivative.expiration_date: Phantom stock units are settled in cash upon termination of service as director. F4 · balance_after: Includes 39.31 units for dividend credits. Read SEC document |
| June 13, 2017 Filed Jun 15, 2017 17:22 UTC | LOEWS CORP L · Entity 3231 | GrantRestricted Stock Units · Derivative | 2.8 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-17-025117 · doc1.xml · derivative · entry 1 WELTERS ANTHONY · CIK 0001213307 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,133.8 Underlying: Common Stock · 2.8 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's common stock. F2 · shares: Represents additional RSUs awarded to the Reporting Person on account of dividend equivalent rights associated with RSUs awarded on May 9, 2017 (the "2017 RSUs"). F3 · derivative.exercise_date: These RSUs vest, and shares of the Issuer's common stock will be delivered to the Reporting Person, concurrently with the 2017 RSUs, subject to any election to defer delivery of shares made by the Reporting Person with respect to such 2017 RSUs. F3 · derivative.expiration_date: These RSUs vest, and shares of the Issuer's common stock will be delivered to the Reporting Person, concurrently with the 2017 RSUs, subject to any election to defer delivery of shares made by the Reporting Person with respect to such 2017 RSUs. Read SEC document |
| May 30, 2017 Filed Jun 1, 2017 12:40 UTC | BARD C R INC /NJ/ BCR · Entity 170698 | Exercise / conversionOption (Right to Buy) · Derivative | 1,200 | $0.00 Strike: $81.70 | $0.00 |
DisclosureSEC source: 0001225208-17-010681 · doc4.xml · derivative · entry 5 WELTERS ANTHONY · CIK 0001213307 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,200 shares Expires 2019-12-09 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · security: Award/Grant pursuant to the 2005 Directors' Stock Award Plan, as amended and restated. F3 · derivative.exercise_date: Options are fully vested. Read SEC document |
| May 30, 2017 Filed Jun 1, 2017 12:40 UTC | BARD C R INC /NJ/ BCR · Entity 170698 | Exercise / conversionOption (Right to Buy) · Derivative | 1,200 | $0.00 Strike: $88.76 | $0.00 |
DisclosureSEC source: 0001225208-17-010681 · doc4.xml · derivative · entry 4 WELTERS ANTHONY · CIK 0001213307 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,200 shares Expires 2018-07-09 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · security: Award/Grant pursuant to the 2005 Directors' Stock Award Plan, as amended and restated. F3 · derivative.exercise_date: Options are fully vested. Read SEC document |
| May 30, 2017 Filed Jun 1, 2017 12:40 UTC | BARD C R INC /NJ/ BCR · Entity 170698 | Tax withholdingCommon Stock | 662 | $309.25 | $204,720.19 |
DisclosureSEC source: 0001225208-17-010681 · doc4.xml · nonDerivative · entry 3 WELTERS ANTHONY · CIK 0001213307 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,222 F1 · kind: In connection with the net exercise of the stock options set forth above, the reporting person forfeited to the issuer an aggregate of 662 shares of common stock underlying such stock options as payment of the exercise price for the stock options, using the fair market value of the common stock price on May 30, 2017 of $309.245. Read SEC document |
| May 30, 2017 Filed Jun 1, 2017 12:40 UTC | BARD C R INC /NJ/ BCR · Entity 170698 | Exercise / conversionCommon Stock | 1,200 | $81.70 | $98,034.00 |
DisclosureSEC source: 0001225208-17-010681 · doc4.xml · nonDerivative · entry 2 WELTERS ANTHONY · CIK 0001213307 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,884 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 30, 2017 Filed Jun 1, 2017 12:40 UTC | BARD C R INC /NJ/ BCR · Entity 170698 | Exercise / conversionCommon Stock | 1,200 | $88.76 | $106,506.00 |
DisclosureSEC source: 0001225208-17-010681 · doc4.xml · nonDerivative · entry 1 WELTERS ANTHONY · CIK 0001213307 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,684 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 24, 2017 Filed May 26, 2017 10:30 UTC | BARD C R INC /NJ/ BCR · Entity 170698 | Exercise / conversionOption (Right to Buy) · Derivative | 1,200 | $0.00 Strike: $83.47 | $0.00 |
DisclosureSEC source: 0001225208-17-010472 · doc4.xml · derivative · entry 3 WELTERS ANTHONY · CIK 0001213307 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,200 shares Expires 2017-07-11 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · security: Award/Grant pursuant to the 2005 Directors' Stock Award Plan, as amended and restated. F3 · derivative.exercise_date: Options are fully vested. Read SEC document |
| May 24, 2017 Filed May 26, 2017 10:30 UTC | BARD C R INC /NJ/ BCR · Entity 170698 | Tax withholdingCommon Stock | 325 | $308.35 | $100,213.75 |
DisclosureSEC source: 0001225208-17-010472 · doc4.xml · nonDerivative · entry 2 WELTERS ANTHONY · CIK 0001213307 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,484 F1 · kind: In connection with the net exercise of the stock option set forth above, the reporting person forfeited to the issuer an aggregate of 325 shares of common stock underlying such stock options as payment of the exercise price for the stock option, using the fair market value of the common stock price on May 24, 2017 of $308.35. Read SEC document |
| May 24, 2017 Filed May 26, 2017 10:30 UTC | BARD C R INC /NJ/ BCR · Entity 170698 | Exercise / conversionCommon Stock | 1,200 | $83.47 | $100,167.60 |
DisclosureSEC source: 0001225208-17-010472 · doc4.xml · nonDerivative · entry 1 WELTERS ANTHONY · CIK 0001213307 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,809 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 10, 2017 Filed May 11, 2017 17:15 UTC | LOEWS CORP L · Entity 3231 | Exercise / conversionRestricted Stock Units · Derivative | 2,534 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-17-019594 · doc1.xml · derivative · entry 3 WELTERS ANTHONY · CIK 0001213307 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,534 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Restricted stock units (each, an "RSU") convert into shares of common stock on a one-for-one basis. F4 · derivative.exercise_date: On May 10, 2016, the Reporting Person was granted 2,520 RSUs, which, together with 14 additional RSUs awarded to the Reporting Person on account of dividend equivalent rights associated with the 2016 RSUs, vest on the first anniversary of the grant date. F4 · derivative.expiration_date: On May 10, 2016, the Reporting Person was granted 2,520 RSUs, which, together with 14 additional RSUs awarded to the Reporting Person on account of dividend equivalent rights associated with the 2016 RSUs, vest on the first anniversary of the grant date. Read SEC document |
| May 10, 2017 Filed May 11, 2017 17:15 UTC | LOEWS CORP L · Entity 3231 | Exercise / conversionCommon Stock | 2,534 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001140361-17-019594 · doc1.xml · nonDerivative · entry 1 WELTERS ANTHONY · CIK 0001213307 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,534 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Restricted stock units (each, an "RSU") convert into shares of common stock on a one-for-one basis. Read SEC document |
| May 09, 2017 Filed May 11, 2017 17:15 UTC | LOEWS CORP L · Entity 3231 | GrantRestricted Stock Units · Derivative | 2,131 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-17-019594 · doc1.xml · derivative · entry 2 WELTERS ANTHONY · CIK 0001213307 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,131 Underlying: Common Stock · 2,131 shares Expires not disclosed F2 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of the Issuer's common stock. F3 · derivative.exercise_date: The RSUs vest on May 9, 2018. Shares of the Issuer's common stock will be delivered to the Reporting Person upon vesting, subject to any election to defer delivery of shares made by the Reporting Person. F3 · derivative.expiration_date: The RSUs vest on May 9, 2018. Shares of the Issuer's common stock will be delivered to the Reporting Person upon vesting, subject to any election to defer delivery of shares made by the Reporting Person. Read SEC document |
| May 01, 2017 Filed May 3, 2017 21:04 UTC | Carlyle Group Inc. CG · Entity 3316 | GrantCommon Units | 5,634 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-17-011659 · doc4.xml · nonDerivative · entry 1 WELTERS ANTHONY · CIK 0001213307 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 39,277 F1 · shares: These securities are deferred restricted common unit awards granted under The Carlyle Group L.P. 2012 Equity Incentive Plan. These securities will vest on May 1, 2018, subject to Mr. Welters's continued service on the board of directors of Carlyle Group Management L.L.C., the general partner of The Carlyle Group L.P., on such vesting date. Read SEC document |
| March 14, 2017 Filed Mar 15, 2017 20:06 UTC | LOEWS CORP L · Entity 3231 | GrantRestricted Stock Units · Derivative | 3.4 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-17-012111 · doc1.xml · derivative · entry 1 WELTERS ANTHONY · CIK 0001213307 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,534.5 Underlying: Common Stock · 3.4 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's common stock. F2 · shares: Represents additional RSUs awarded to the Reporting Person on account of dividend equivalent rights associated with previously awarded RSUs (the "Previous RSUs"). F3 · derivative.exercise_date: These RSUs vest, and shares of the Issuer's common stock will be delivered to the Reporting Person, concurrently with Previous RSUs, subject to any election to defer delivery of shares made by the Reporting Person with respect to such Previous RSUs. F3 · derivative.expiration_date: These RSUs vest, and shares of the Issuer's common stock will be delivered to the Reporting Person, concurrently with Previous RSUs, subject to any election to defer delivery of shares made by the Reporting Person with respect to such Previous RSUs. Read SEC document |
| January 03, 2017 Filed Jan 5, 2017 14:11 UTC | BARD C R INC /NJ/ BCR · Entity 170698 | GrantPhantom Stock Units · Derivative | 227.5 | $227.47 | $51,749.43 |
DisclosureSEC source: 0001225208-17-000580 · doc4.xml · derivative · entry 2 WELTERS ANTHONY · CIK 0001213307 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,272.21 Underlying: Common Stock · 227.5 shares Expires not disclosed F1 · security: Units are credited under the Company's Deferred Compensation Contract, Deferral of Directors' Fees. F2 · derivative.exercise_price: Conversion is 1 for 1. F3 · derivative.exercise_date: Phantom stock units are settled in cash upon termination of service as director. F3 · derivative.expiration_date: Phantom stock units are settled in cash upon termination of service as director. F4 · balance_after: Includes 47.15 units for dividend credits. Read SEC document |
| December 21, 2016 Filed Jan 5, 2017 14:11 UTC | BARD C R INC /NJ/ BCR · Entity 170698 | GiftCommon Stock | 767 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-17-000580 · doc4.xml · nonDerivative · entry 1 WELTERS ANTHONY · CIK 0001213307 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,609 Read SEC document |
| December 14, 2016 Filed Dec 15, 2016 15:58 UTC | BARD C R INC /NJ/ BCR · Entity 170698 | GrantShare Equivalent Units · Derivative | 375 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-16-043309 · doc4.xml · derivative · entry 2 WELTERS ANTHONY · CIK 0001213307 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,563 Underlying: Common Stock · 375 shares Expires not disclosed F2 · security: Units granted under the Company's Stock Equivalent Plan for Outside Directors. F3 · derivative.exercise_price: Conversion is 1 for 1. F4 · derivative.exercise_date: Share Equivalent Units are settled in cash upon termination as a director. F4 · derivative.expiration_date: Share Equivalent Units are settled in cash upon termination as a director. Read SEC document |
| December 14, 2016 Filed Dec 15, 2016 15:58 UTC | BARD C R INC /NJ/ BCR · Entity 170698 | GrantCommon Stock | 468 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-16-043309 · doc4.xml · nonDerivative · entry 1 WELTERS ANTHONY · CIK 0001213307 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,376 F1 · kind: Stock award granted in accordance with the 2005 Directors' Stock Award Plan, as amended and restated, that fully vests in three years from the date of grant. Read SEC document |
| December 13, 2016 Filed Dec 15, 2016 21:15 UTC | LOEWS CORP L · Entity 3231 | GrantRestricted Stock Units · Derivative | 3.3 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-16-089832 · doc1.xml · derivative · entry 1 WELTERS ANTHONY · CIK 0001213307 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,531.1 Underlying: Common Stock · 3.3 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's common stock. F2 · shares: Represents additional RSUs awarded to the Reporting Person on account of dividend equivalent rights associated with previously awarded RSUs (the "Previous RSUs"). F3 · derivative.exercise_date: These RSUs vest, and shares of the Issuer's common stock will be delivered to the Reporting Person, concurrently with Previous RSUs, subject to any election to defer delivery of shares made by the Reporting Person with respect to such Previous RSUs. F3 · derivative.expiration_date: These RSUs vest, and shares of the Issuer's common stock will be delivered to the Reporting Person, concurrently with Previous RSUs, subject to any election to defer delivery of shares made by the Reporting Person with respect to such Previous RSUs. Read SEC document |
| September 13, 2016 Filed Sep 14, 2016 17:04 UTC | LOEWS CORP L · Entity 3231 | GrantRestricted Stock Units · Derivative | 3.8 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-16-079748 · doc1.xml · derivative · entry 1 WELTERS ANTHONY · CIK 0001213307 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,527.8 Underlying: Common Stock · 3.8 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's common stock. F2 · shares: Represents additional RSUs awarded to the Reporting Person on account of dividend equivalent rights associated with previously awarded RSUs (the "Previous RSUs"). F3 · derivative.exercise_date: These RSUs vest, and shares of the Issuer's common stock will be delivered to the Reporting Person, concurrently with Previous RSUs, subject to any election to defer delivery of shares made by the Reporting Person with respect to such Previous RSUs. F3 · derivative.expiration_date: These RSUs vest, and shares of the Issuer's common stock will be delivered to the Reporting Person, concurrently with Previous RSUs, subject to any election to defer delivery of shares made by the Reporting Person with respect to such Previous RSUs. Read SEC document |
| June 05, 2012 Filed Jun 7, 2012 21:31 UTC | UNITEDHEALTH GROUP INC UNH · Entity 2809 | Tax withholdingCommon Stock | 7,211 | $56.04 | $404,104.44 |
DisclosureSEC source: 0001209191-12-032851 · doc4.xml · nonDerivative · entry 1 WELTERS ANTHONY · CIK 0001213307 · EVP, UnitedHealth Group 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 119,908.836 Read SEC document |
| April 23, 2012 Filed Apr 24, 2012 21:13 UTC | UNITEDHEALTH GROUP INC UNH · Entity 2809 | Exercise / conversionStock Appreciation Right · Derivative | 38,012 | $0.00 Strike: $33.00 | $0.00 |
DisclosureSEC source: 0001209191-12-024042 · doc4.xml · derivative · entry 12 WELTERS ANTHONY · CIK 0001213307 · EVP, UnitedHealth Group 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,012 Underlying: Common Stock · 38,012 shares Expires 2020-02-09 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 23, 2012 Filed Apr 24, 2012 21:13 UTC | UNITEDHEALTH GROUP INC UNH · Entity 2809 | Exercise / conversionStock Appreciation Right · Derivative | 28,280 | $0.00 Strike: $29.74 | $0.00 |
DisclosureSEC source: 0001209191-12-024042 · doc4.xml · derivative · entry 11 WELTERS ANTHONY · CIK 0001213307 · EVP, UnitedHealth Group 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,280 Underlying: Common Stock · 28,280 shares Expires 2019-02-23 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 23, 2012 Filed Apr 24, 2012 21:13 UTC | UNITEDHEALTH GROUP INC UNH · Entity 2809 | Exercise / conversionStock Appreciation Right · Derivative | 23,639 | $0.00 Strike: $33.94 | $0.00 |
DisclosureSEC source: 0001209191-12-024042 · doc4.xml · derivative · entry 10 WELTERS ANTHONY · CIK 0001213307 · EVP, UnitedHealth Group 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,212 Underlying: Common Stock · 23,639 shares Expires 2018-06-05 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 23, 2012 Filed Apr 24, 2012 21:13 UTC | UNITEDHEALTH GROUP INC UNH · Entity 2809 | Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 70,000 | $0.00 Strike: $42.87 | $0.00 |
DisclosureSEC source: 0001209191-12-024042 · doc4.xml · derivative · entry 9 WELTERS ANTHONY · CIK 0001213307 · EVP, UnitedHealth Group 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 200,000 Underlying: Common Stock · 70,000 shares Expires 2014-11-04 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 23, 2012 Filed Apr 24, 2012 21:13 UTC | UNITEDHEALTH GROUP INC UNH · Entity 2809 | SaleCommon Stock | 90,571 | $59.07 | $5,349,775.37 |
DisclosureSEC source: 0001209191-12-024042 · doc4.xml · nonDerivative · entry 8 WELTERS ANTHONY · CIK 0001213307 · EVP, UnitedHealth Group 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 127,119.836 F1 · price: This transaction was executed in multiple trades ranging from $59.03 to $59.202 per share. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer, or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected. Read SEC document |
| April 23, 2012 Filed Apr 24, 2012 21:13 UTC | UNITEDHEALTH GROUP INC UNH · Entity 2809 | Tax withholdingCommon Stock | 28,225 | $59.51 | $1,679,669.75 |
DisclosureSEC source: 0001209191-12-024042 · doc4.xml · nonDerivative · entry 7 WELTERS ANTHONY · CIK 0001213307 · EVP, UnitedHealth Group 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 217,690.836 Read SEC document |
| April 23, 2012 Filed Apr 24, 2012 21:13 UTC | UNITEDHEALTH GROUP INC UNH · Entity 2809 | Exercise / conversionCommon Stock | 38,012 | $33.00 | $1,254,396.00 |
DisclosureSEC source: 0001209191-12-024042 · doc4.xml · nonDerivative · entry 6 WELTERS ANTHONY · CIK 0001213307 · EVP, UnitedHealth Group 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 245,915.836 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 23, 2012 Filed Apr 24, 2012 21:13 UTC | UNITEDHEALTH GROUP INC UNH · Entity 2809 | Tax withholdingCommon Stock | 20,103 | $59.51 | $1,196,329.53 |
DisclosureSEC source: 0001209191-12-024042 · doc4.xml · nonDerivative · entry 5 WELTERS ANTHONY · CIK 0001213307 · EVP, UnitedHealth Group 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 207,903.836 Read SEC document |
| April 23, 2012 Filed Apr 24, 2012 21:13 UTC | UNITEDHEALTH GROUP INC UNH · Entity 2809 | Exercise / conversionCommon Stock | 28,280 | $29.74 | $841,047.20 |
DisclosureSEC source: 0001209191-12-024042 · doc4.xml · nonDerivative · entry 4 WELTERS ANTHONY · CIK 0001213307 · EVP, UnitedHealth Group 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 228,006.836 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 23, 2012 Filed Apr 24, 2012 21:13 UTC | UNITEDHEALTH GROUP INC UNH · Entity 2809 | Tax withholdingCommon Stock | 17,769 | $59.51 | $1,057,433.19 |
DisclosureSEC source: 0001209191-12-024042 · doc4.xml · nonDerivative · entry 3 WELTERS ANTHONY · CIK 0001213307 · EVP, UnitedHealth Group 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 199,726.836 Read SEC document |
| April 23, 2012 Filed Apr 24, 2012 21:13 UTC | UNITEDHEALTH GROUP INC UNH · Entity 2809 | Exercise / conversionCommon Stock | 23,639 | $33.94 | $802,307.66 |
DisclosureSEC source: 0001209191-12-024042 · doc4.xml · nonDerivative · entry 2 WELTERS ANTHONY · CIK 0001213307 · EVP, UnitedHealth Group 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 217,495.836 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 23, 2012 Filed Apr 24, 2012 21:13 UTC | UNITEDHEALTH GROUP INC UNH · Entity 2809 | Exercise / conversionCommon Stock | 70,000 | $42.87 | $3,000,550.00 |
DisclosureSEC source: 0001209191-12-024042 · doc4.xml · nonDerivative · entry 1 WELTERS ANTHONY · CIK 0001213307 · EVP, UnitedHealth Group 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 193,856.836 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 19, 2012 Filed Mar 20, 2012 21:43 UTC | UNITEDHEALTH GROUP INC UNH · Entity 2809 | GrantCommon Stock | 215.824 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-12-019224 · doc4.xml · nonDerivative · entry 1 WELTERS ANTHONY · CIK 0001213307 · EVP, UnitedHealth Group 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 123,856.836 F1 · shares: Represents payment of dividend equivalents on outstanding restricted stock units. The dividend equivalents are subject to the same terms as the underlying restricted stock units and are forfeited if the related award does not vest. Read SEC document |
| March 08, 2012 Filed Mar 9, 2012 22:45 UTC | UNITEDHEALTH GROUP INC UNH · Entity 2809 | SaleCommon Stock | 30,000 | $55.54 | $1,666,266.00 |
DisclosureSEC source: 0001209191-12-017296 · doc4.xml · nonDerivative · entry 1 WELTERS ANTHONY · CIK 0001213307 · EVP, UnitedHealth Group 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 123,641.012 F1 · price: This transaction was executed in multiple trades ranging from $55.52 to $55.61 per share. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer, or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected. Read SEC document |
| February 13, 2012 Filed Feb 14, 2012 21:46 UTC | UNITEDHEALTH GROUP INC UNH · Entity 2809 | SaleCommon Stock | 76,000 | $53.58 | $4,071,753.20 |
DisclosureSEC source: 0001209191-12-009974 · doc4.xml · nonDerivative · entry 1 WELTERS ANTHONY · CIK 0001213307 · EVP, UnitedHealth Group 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 153,641.012 F1 · price: This transaction was executed in multiple trades ranging from $53.41 to $53.65 per share. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer, or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected. Read SEC document |
| February 09, 2012 Filed Feb 10, 2012 21:35 UTC | UNITEDHEALTH GROUP INC UNH · Entity 2809 | Tax withholdingCommon Stock | 3,088 | $53.06 | $163,849.28 |
DisclosureSEC source: 0001209191-12-009066 · doc4.xml · nonDerivative · entry 2 WELTERS ANTHONY · CIK 0001213307 · EVP, UnitedHealth Group 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 229,641.012 Read SEC document |
| February 09, 2012 Filed Feb 10, 2012 21:35 UTC | UNITEDHEALTH GROUP INC UNH · Entity 2809 | Tax withholdingCommon Stock | 5,862 | $53.06 | $311,037.72 |
DisclosureSEC source: 0001209191-12-009066 · doc4.xml · nonDerivative · entry 1 WELTERS ANTHONY · CIK 0001213307 · EVP, UnitedHealth Group 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 232,729.012 Read SEC document |
| February 07, 2012 Filed Feb 9, 2012 21:42 UTC | UNITEDHEALTH GROUP INC UNH · Entity 2809 | Tax withholdingCommon Stock | 64,924 | $52.03 | $3,377,995.72 |
DisclosureSEC source: 0001209191-12-008722 · doc4.xml · nonDerivative · entry 3 WELTERS ANTHONY · CIK 0001213307 · EVP, UnitedHealth Group 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 238,591.012 F3 · shares: Represents the withholding of shares to satisfy tax obligations upon the settlement of Performance Share Awards for the performance period 2009-2011. F4 · balance_after: Amount does not include performance-based restricted stock units granted to the executive officer on February 7, 2012, as performance awards not tied to stock price are not derivative securities for purposes of Section 16 under guidance from the staff of the SEC. The number of performance-based restricted stock units that the executive officer will receive will be determined at the end of the 3-year performance period and will be dependent upon the achievement of cumulative 3-year EPS and average return-on-equity performance metrics approved by the Compensation and Human Resources Committee. The target number of performance-based restricted stock units is 38,440. Read SEC document |
| February 07, 2012 Filed Feb 9, 2012 21:42 UTC | UNITEDHEALTH GROUP INC UNH · Entity 2809 | GrantCommon Stock | 153,846 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-12-008722 · doc4.xml · nonDerivative · entry 2 WELTERS ANTHONY · CIK 0001213307 · EVP, UnitedHealth Group 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 303,515.012 F2 · shares: Represents the settlement of Performance Share Awards for the performance period 2009-2011. Read SEC document |
| February 07, 2012 Filed Feb 9, 2012 21:42 UTC | UNITEDHEALTH GROUP INC UNH · Entity 2809 | GrantCommon Stock | 38,440 | $52.03 | $2,000,033.20 |
DisclosureSEC source: 0001209191-12-008722 · doc4.xml · nonDerivative · entry 1 WELTERS ANTHONY · CIK 0001213307 · EVP, UnitedHealth Group 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 149,669.012 F1 · shares: The restricted stock units will vest at a rate of 33% on December 28, 2012; February 7, 2014; and February 7, 2015. Read SEC document |
| February 03, 2012 Filed Feb 7, 2012 21:51 UTC | UNITEDHEALTH GROUP INC UNH · Entity 2809 | Tax withholdingCommon Stock | 2,957 | $51.31 | $151,723.67 |
DisclosureSEC source: 0001209191-12-008176 · doc4.xml · nonDerivative · entry 1 WELTERS ANTHONY · CIK 0001213307 · EVP, UnitedHealth Group 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 111,229.012 F1 · balance_after: Includes shares received through UnitedHealth Group Incorporated's Employee Stock Purchase Plan. Read SEC document |
| December 21, 2011 Filed Dec 22, 2011 23:39 UTC | UNITEDHEALTH GROUP INC UNH · Entity 2809 | Tax withholdingCommon Stock | 1,325 | $49.99 | $66,236.75 |
DisclosureSEC source: 0001209191-11-062898 · doc4.xml · nonDerivative · entry 2 WELTERS ANTHONY · CIK 0001213307 · EVP, UnitedHealth Group 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 114,158.239 F3 · shares: Represents the cancellation of shares for the payment of a FICA tax liability. F2 · balance_after: Includes shares received through UnitedHealth Group Incorporated's Employee Stock Purchase Plan. Read SEC document |
| December 21, 2011 Filed Dec 22, 2011 23:39 UTC | UNITEDHEALTH GROUP INC UNH · Entity 2809 | GrantCommon Stock | 175.492 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-11-062898 · doc4.xml · nonDerivative · entry 1 WELTERS ANTHONY · CIK 0001213307 · EVP, UnitedHealth Group 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 115,483.239 F1 · shares: Represents payment of dividend equivalents on outstanding restricted stock units. The dividend equivalents are subject to the same terms as the underlying restricted stock units and are forfeited if the related award does not vest. F2 · balance_after: Includes shares received through UnitedHealth Group Incorporated's Employee Stock Purchase Plan. Read SEC document |
| December 14, 2011 Filed Dec 15, 2011 22:35 UTC | UNITEDHEALTH GROUP INC UNH · Entity 2809 | SaleCommon Stock | 18,254 | $48.16 | $879,136.37 |
DisclosureSEC source: 0001209191-11-061540 · doc4.xml · nonDerivative · entry 5 WELTERS ANTHONY · CIK 0001213307 · EVP, UnitedHealth Group 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 114,656.281 F1 · price: This transaction was executed in multiple trades ranging from $48.16 to $48.17 per share. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer, or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected. Read SEC document |
| December 13, 2011 Filed Dec 15, 2011 22:35 UTC | UNITEDHEALTH GROUP INC UNH · Entity 2809 | Exercise / conversionStock Appreciation Right · Derivative | 51,562 | $0.00 Strike: $29.74 | $0.00 |
DisclosureSEC source: 0001209191-11-061540 · doc4.xml · derivative · entry 7 WELTERS ANTHONY · CIK 0001213307 · EVP, UnitedHealth Group 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 56,560 Underlying: Common Stock · 51,562 shares Expires 2019-02-23 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The stock appreciation rights vest at a rate of 25% annually on February 3 from the years 2010 through 2013. Read SEC document |
| December 13, 2011 Filed Dec 15, 2011 22:35 UTC | UNITEDHEALTH GROUP INC UNH · Entity 2809 | Exercise / conversionStock Appreciation Right · Derivative | 40,000 | $0.00 Strike: $33.94 | $0.00 |
DisclosureSEC source: 0001209191-11-061540 · doc4.xml · derivative · entry 6 WELTERS ANTHONY · CIK 0001213307 · EVP, UnitedHealth Group 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44,851 Underlying: Common Stock · 40,000 shares Expires 2018-06-05 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The stock appreciation rights vest at a rate of 25% annually on June 5 from the years 2009 through 2012. Read SEC document |
| December 13, 2011 Filed Dec 15, 2011 22:35 UTC | UNITEDHEALTH GROUP INC UNH · Entity 2809 | Tax withholdingCommon Stock | 40,148 | $48.20 | $1,935,133.60 |
DisclosureSEC source: 0001209191-11-061540 · doc4.xml · nonDerivative · entry 4 WELTERS ANTHONY · CIK 0001213307 · EVP, UnitedHealth Group 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 132,910.281 Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.